During inflammation, immune cells release various mediators that can exacerbate the inflammatory response. RvD1 acts to counterbalance these effects by inhibiting the production of pro-inflammatory cytokines and reducing the migration of leukocytes to the inflamed tissue. It also promotes the phagocytosis of apoptotic cells by macrophages, a process known as efferocytosis, which is essential for resolving inflammation and repairing tissue damage.
